Advances and current status of stem cell transplantation in treatment of hematological malignancies in China / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 485-489, 2019.
Article
Dans Chinois
| WPRIM
| ID: wpr-751429
ABSTRACT
Since the founding of the People's Republic of China, much progress has been made in the field of stem cell transplantation by Chinese scholars. From the successful treatment of the first case with syngeneic bone marrow transplantation to the international original establishment of T-cell-replete haploidentical blood and marrow transplant system (known as the "Beijing Protocol"). The transformation of hematopoietic stem cell transplantation from "follow-up" to "lead-up" has been realized, and the problem of donor source has been basically solved. This article summarized the development status of stem cell transplantation in treatment of hematological malignancies in China, and the challenges that need to be addressed.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Guide de pratique
langue:
Chinois
Texte intégral:
Journal of Leukemia & Lymphoma
Année:
2019
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS